Direktorat Registrasi ObatValid

AMLODIPINE BESILATE

BPOM Number: GKL2609614710B1
Approved: 23 June 2026
Expiry: 24 May 2031
Form: Tablet

About This Registration

AMLODIPINE BESILATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2609614710B1. Its current registration status is Valid, with the licence valid until 24 May 2031. The product is registered to IMFARMIND FARMASI INDUSTRI - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 1 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 TABLET
Department: Direktorat Registrasi Obat
Data Last Updated: 1 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

IMFARMIND FARMASI INDUSTRI - INDONESIA
KAB. PASURUAN
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

IMFARMIND FARMASI INDUSTRI - INDONESIA
KAB. PASURUAN
primary
View profile →

Ingredients (1)

AMLODIPINE BESILATE

Market Intelligence

Owner Portfolio: IMFARMIND FARMASI INDUSTRI - INDONESIA holds 99 BPOM registrations
Manufacturer Scale: IMFARMIND FARMASI INDUSTRI - INDONESIA produces 99 registered products
Registration Age: Registered for 1 month
Update Status: Recently updated (24 days ago)

FDA Cross-Reference

via openFDA

Generic Name: AMLODIPINE BESYLATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?